Read More Pharma Industry News Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal Antengene (SEHK: 6996.HK) presents ATG-125, ATG-106, and ATG-112 preclinical data at AACR 2026. Read what the results mean for its pipeline strategy. byVenkateshApril 18, 2026